Howard Fillit

Howard Fillit, M.D., is founding executive director and Chief Science Officer of the Alzheimer's Drug Discovery Foundation. He is a clinical professor of Geriatric Medicine, Palliative Care & Neuroscience at the Icahn School of Medicine at Mount Sinai. The ADDF is not an investor in Biogen or aducanamab.

OPINION June 8, 2021

Dr. Howard Fillit: Why Alzheimer's milestone, new research gives me hope for millions of patients and families

Many patient advocacy groups representing the 6 million Americans suffering from Alzheimer’s disease are hailing the FDA’s approval of a new treatment for Alzheimer’s, aducanamab – the first since 2003.